14th February 2024

A new medication has been introduced to treat patients with early-stage idiopathic pulmonary fibrosis.

A new medication has been introduced to treat patients with early-stage idiopathic pulmonary fibrosis. A study recruited 700 patients with early-stage pulmonary fibrosis and was divided into two groups. 300 patients were given the new treatment, while 400 were given a placebo. Of these patients, 150 patients on the new treatment and 30 on the placebo described an improvement. 

What is the number needed to treat this new medication?